4.7 Article

Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors

Journal

HYPERTENSION
Volume 49, Issue 3, Pages 590-596

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/01.HYP.0000255173.50317.fc

Keywords

cytochrome P450 system; endothelium; arachidonic acid; vascular relaxation; endothelium-derived hyperpolarizing factor

Funding

  1. NHLBI NIH HHS [HL-51055, HL-37981] Funding Source: Medline
  2. NIDDK NIH HHS [DK-58145, DK-38266] Funding Source: Medline
  3. NIGMS NIH HHS [GM-31278] Funding Source: Medline

Ask authors/readers for more resources

The endothelium regulates vascular tone through the release of a number of soluble mediators, including NO, prostaglandin I-2, and endothelium-derived hyperpolarizing factor. Epoxyeicosatrienoic acids are cytochrome P450 epoxygenase metabolites of arachidonic acid. They are synthesized by the vascular endothelium and open calcium-activated potassium channels, hyperpolarize the membrane, and relax vascular smooth muscle. Endothelium-dependent relaxations to acetylcholine, bradykinin, and shear stress that are not inhibited by cyclooxygenase and NO synthase inhibitors are mediated by the endothelium-derived hyperpolarizing factor. In arteries from experimental animals and humans, the non-NO, non-prostaglandin-mediated relaxations and endothelium-dependent hyperpolarizations are blocked by cytochrome P450 inhibitors, calcium-activated potassium channel blockers, and epoxyeicosatrienoic acid antagonists. Acetylcholine and bradykinin stimulate epoxyeicosatrienoic acid release from endothelial cells and arteries. These findings indicate that epoxyeicosatrienoic acids act as endothelium-derived hyperpolarizing factors and regulate arterial tone.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available